The landscape of chimeric antigen receptor T cell therapy in breast cancer: Perspectives and outlook

Chimeric antigen receptor-T (CAR-T) cell therapy is a revolutionary adoptive cell therapy, which could modify and redirect T cells to specific tumor cells. Since CAR-T cell therapy was first approved for B cell-derived malignancies in 2017, it has yielded unprecedented progress in hematological tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hao, Zhu, Shuangli, Deng, Wanjun, Li, Rui, Zhou, Haiting, Xiong, Huihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354605/
https://www.ncbi.nlm.nih.gov/pubmed/35935930
http://dx.doi.org/10.3389/fimmu.2022.887471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354605/
https://www.ncbi.nlm.nih.gov/pubmed/35935930
http://dx.doi.org/10.3389/fimmu.2022.887471

Ejemplares similares